BPCE
BSX icon

Bank Pictet & Cie (Europe)’s Boston Scientific BSX Stock Holding History

Bank Pictet & Cie (Europe)’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$30.6M Buy
717,973
+76,739
+12% +$4.17M 0.6% 37
2026
Q1 		$40.2M Buy
641,234
+486,715
+315% +$38.9M 0.86% 34
2025
Q4 		$14.7M Sell
154,519
-3,417
-2% -$335K 0.29% 64
2025
Q3 		$15.4M Sell
157,936
-6,718
-4% -$696K 0.31% 60
2025
Q2 		$17.7M Buy
164,654
+70,753
+75% +$7.16M 0.38% 57
2025
Q1 		$9.47M Buy
93,901
+20,805
+28% +$2.09M 0.23% 66
2024
Q4 		$6.53M Buy
73,096
+21,173
+41% +$1.86M 0.14% 78
2024
Q3 		$4.35M Sell
51,923
-27,416
-35% -$2.16M 0.1% 78
2024
Q2 		$6.11M Buy
79,339
+23,486
+42% +$1.72M 0.15% 72
2024
Q1 		$3.83M Sell
55,853
-1,846
-3% -$119K 0.1% 82
2023
Q4 		$3.34M Sell
57,699
-95,504
-62% -$5.1M 0.1% 96
2023
Q3 		$8.09M Buy
153,203
+131,853
+618% +$6.92M 0.28% 65
2023
Q2 		$1.15M Buy
21,350
+2,072
+11% +$108K 0.04% 132
2023
Q1 		$964K Buy
19,278
+563
+3% +$26.5K 0.04% 108
2022
Q4 		$866K Buy
18,715
+200
+1% +$8.66K 0.04% 106
2022
Q3 		$717K Sell
18,515
-8,734
-32% -$350K 0.04% 111
2022
Q2 		$1.02M Sell
27,249
-10,545
-28% -$429K 0.05% 98
2022
Q1 		$1.67M Sell
37,794
-543
-1% -$23.5K 0.06% 91
2021
Q4 		$1.63M Sell
38,337
-77,100
-67% -$3.24M 0.06% 92
2021
Q3 		$5.01M Sell
115,437
-239,695
-67% -$10.6M 0.19% 69
2021
Q2 		$15.2M Sell
355,132
-310,329
-47% -$13.1M 0.53% 43
2021
Q1 		$25.7M Buy
665,461
+31,473
+5% +$1.19M 1.03% 31
2020
Q4 		$22.8M Buy
633,988
+620,800
+4,707% +$22.4M 1.12% 32
2020
Q3 		$504K Sell
13,188
-6,730
-34% -$259K 0.03% 96
2020
Q2 		$699K Buy
19,918
+2,987
+18% +$108K 0.05% 82
2020
Q1 		$552K Buy
16,931
+164
+1% +$6.41K 0.05% 87
2019
Q4 		$758K Sell
16,767
-3,010
-15% -$126K 0.11% 85
2019
Q3 		$805K Sell
19,777
-370
-2% -$15.7K 0.14% 80
2019
Q2 		$866K Buy
20,147
+14,177
+237% +$545K 0.15% 74
2019
Q1 		$229K Sell
5,970
-9,370
-61% -$358K 0.04% 144
2018
Q4 		$542K Buy
15,340
+3,170
+26% +$115K 0.11% 74
2018
Q3 		$469K Buy
+12,170
New +$425K 0.07% 131

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $31.4B AUM 31.97% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Bank Pictet & Cie (Europe)'s BSX Position: Q2 2026 in Review

Bank Pictet & Cie (Europe) increased its Boston Scientific (BSX) stake by 12% in Q2 2026, buying an estimated $4.17M and bringing the position to 717,973 shares worth $30.6M. The position accounts for 0.6% of the portfolio, ranked #37.

Bank Pictet & Cie (Europe) first reported a position in BSX in Q3 2018 and has held it in 32 quarters since. The position peaked at $40.2M in Q1 2026. 770 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Bank Pictet & Cie (Europe) held 717,973 shares of Boston Scientific worth $30.6M as of Q2 2026.
  • Bank Pictet & Cie (Europe) bought 76,739 Boston Scientific shares in Q2 2026, an estimated $4.17M.
  • Boston Scientific made up 0.6% of Bank Pictet & Cie (Europe)'s portfolio in Q2 2026, its #37 holding.
  • Bank Pictet & Cie (Europe) first reported a position in Boston Scientific in Q3 2018 and has held it in 32 quarters since.
  • Bank Pictet & Cie (Europe)'s Boston Scientific position peaked at $40.2M in Q1 2026.
  • 770 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Bank Pictet & Cie (Europe)'s 13F filing for Q2 2026, filed 24 Jul 2026.